Alliance to buy PET/CT provider for $43M

TriMed Staff | | Health Imaging | Screening
 
Alliance seeks to expand more into the SPECT/CT market. Image Source: University Hospital Zurich/SNM 
Alliance Imaging, a provider of outpatient diagnostic imaging services and radiation therapy services, has entered an agreement to acquire Shared P.E.T. Imaging (SPI), a mobile and fixed-site provider of PET/CT in Canton, Ohio.

The company said that the total purchase price of SPI is expected to total approximately $43 million in cash and assumed indebtedness.

“Alliance believes that the expansion of PET/CT’s critical role in cancer detection and related treatment planning will result in continued overall growth in patient procedures. As part of our plan to expand Alliance’s strategic position as a national leader in PET/CT services, we are pleased to be able to move forward and combine our respective organizations in the Midwest, Southeast and Northeast United States,” said Paul S. Viviano, chairman of the board and CEO of the Newport Beach, Calif.-based Alliance.

SPI currently generates approximately $29 million of annual revenue and serves approximately 90 clients in 13 states, including Ohio, Michigan, Indiana, Illinois, Florida, Pennsylvania, New York, Tennessee and South Carolina, according to Alliance.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.